Cite
HARVARD Citation
Bar-Gil Shitrit, A. et al. (2020). Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn's disease: A multicenter Israeli study. United European Gastroenterology journal. 8 (4), pp. 418-424. [Online].